betamethasone has been researched along with suramin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Anderson, J; Fuglsang, H | 1 |
Montesano, R; Orci, L; Pepper, MS; Schweigerer, L; Vassalli, JD; Wilks, JW | 1 |
5 other study(ies) available for betamethasone and suramin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.
Topics: Adolescent; Adult; Betamethasone; Child; Diethylcarbamazine; Drug Therapy, Combination; Eye Diseases; Female; Humans; Male; Middle Aged; Onchocerciasis; Suramin; Visual Acuity | 1978 |
Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis.
Topics: Adrenal Cortex; Animals; Betamethasone; Cattle; Cell Division; Cells, Cultured; Endopeptidases; Endothelium, Vascular; Fibroblast Growth Factor 2; Gene Expression; Heparin; Humans; Interferon alpha-2; Interferon-alpha; Microcirculation; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Recombinant Proteins; Suramin; Transcription, Genetic; Tretinoin; Urokinase-Type Plasminogen Activator | 1994 |